midazolam has been researched along with Ventricular Dysfunction in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNulty, SE | 1 |
| Gratch, D | 1 |
| Costello, D | 1 |
| Heropoulos, M | 1 |
| Kim, JY | 1 |
1 trial available for midazolam and Ventricular Dysfunction
| Article | Year |
|---|---|
The effect of midazolam and lorazepam on postoperative recovery after cardiac surgery.
Topics: Age Factors; Aged; Anesthesia Recovery Period; Awareness; Coronary Artery Bypass; Female; Humans; In | 1995 |